Dishman Pharmaceuticals and Chemicals Limited

NSE: DISHMAN | BSE: 532526 | ISIN: INE353G01020 | Industry: Pharmaceuticals
|

Karvy
Margins and PAT above expectation: Total Revenues for the quarter grew by 4.2% to Rs 4274 mn, which includesRs 516 mn of other operating income. EBITDA was up by 9.1% YoY to Rs1327 mn on account of better gross margins.
More from Dishman Pharmaceuticals and Chemicals Limited
Recommended